ABCLAbCellera Biologics Inc.同业对比
AbCellera Biologics Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCL本股 | $3.8B#8 | — | 4.2x#8 | 50.0x#6 | 160.6%#2 | 10.1%#7 | -289.0%#7 | -16.3%#10 | -28.0%#4 | — | 128.6%#1 | — |
| TVTX | $4.6B#1 | — | 203.9x#15 | 9.4x#3 | 110.5%#3 | 92.1%#1 | -12.8%#4 | -113.1%#15 | — | — | — | — |
| GOSS | $4.4B#2 | — | — | 91.3x#8 | -57.7%#8 | -201.4%#14 | -352.2%#8 | — | — | — | — | — |
| GPCR | $4.4B#3 | — | 3.2x#4 | — | — | -15.2%#8 | — | -10.4%#8 | — | — | — | — |
| EWTX | $4.2B#4 | — | 9.3x#11 | — | — | -25.4%#10 | — | -0.0%#5 | -50.9%#6 | — | 112.7%#2 | — |
| ARQT | $4.1B#5 | 146.6x#4 | 18.4x#13 | 10.8x#4 | 91.3%#4 | 88.5%#2 | -3.3%#3 | -7.3%#6 | -4.1%#3 | — | — | — |
| TNGX | $4.0B#6 | — | 3.9x#7 | 64.5x#7 | 48.3%#5 | 22.0%#6 | -178.4%#6 | -9.9%#7 | — | — | — | — |
| LQDA | $3.8B#7 | 30.1x#3 | 19.3x#14 | 23.8x#5 | 1031.2%#1 | 47.1%#5 | -32.5%#5 | -35.3%#12 | — | — | 66.8%#3 | — |
| XENE | $3.8B#9 | — | 3.0x#2 | 500.3x#9 | — | -47.6%#12 | -4974.3%#9 | -27.8%#11 | -32.5%#5 | — | — | — |
| OGN | $3.6B#10 | 17.8x#2 | 3.0x#3 | 0.6x#1 | -2.9%#7 | -78.4%#13 | 14.9%#1 | 15.7%#2 | 4.9%#2 | 5#1 | — | 2.4%#1 |
| PBLS | $3.6B#11 | — | 3.4x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ACAD | $3.6B#12 | 9.3x#1 | 2.7x#1 | 3.3x#2 | 11.9%#6 | 73.0%#3 | 9.8%#2 | 29.9%#1 | 11.4%#1 | — | — | — |
| VKTX | $3.4B#13 | — | 5.8x#10 | — | — | -227.1%#15 | — | -61.1%#14 | — | — | -26.0%#4 | — |
| DYN | $3.4B#14 | — | 4.8x#9 | — | — | -40.6%#11 | — | -0.0%#4 | -1301.5%#7 | — | — | — |
| ELVN | $3.3B#15 | — | 3.7x#6 | — | — | -16.5%#9 | — | -11.6%#9 | — | — | — | — |
| AMLX | $3.3B#16 | — | 13.7x#12 | — | -100.0%#9 | 52.0%#4 | — | -60.5%#13 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议